Xie X, Fu Y, Gan L, Yang X, et al. Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study. AIDS 2025 Jan 27. doi: 10.1097/QAD.0000000000004130.
PMID: 39874112